top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Autore Ecke Thorsten
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (240 p.)
Soggetto topico Medicine
Soggetto non controllato adjuvant chemotherapy
androgen receptor
BCG therapy
biomarker
biomarkers
BIRC5
bladder
bladder cancer
bladder cancer detection
cadmium exposure
cancer
chemotherapy
combination therapy
DNA methylation
drug resistance
ECRG4
ERBB2
F-actin
FGFR3
grade
heparan sulfate proteoglycans (HSPGs)
heparanase
histone demethylase
immunotherapy
invasion
ITIH5
JAK inhibitor
JAK-STAT pathway
KDM7A
KRT20
macrophage
metabolomics
Metallothionein
MIBC
miRNA
MS
muscle-invasive bladder cancer
n/a
NMR
non muscle invasive bladder cancer
non-invasive detection
oncolytic adenovirus
p53
personalized medicine
prediction
predictive biomarker
prognosis
proliferation
PTEN
quantitative PCR
RT-qPCR
somatic mutations
STAT3/5 inhibitor
survival
survivin
syndecan-1
TAGLN
TC-E 5002
telomerase
TERT promoter mutations
TERT promoter region
tumor marker
tumor markers
tumorigenesis
urinary biomarkers
urothelial cancer
urothelial carcinoma
urothelium
virotherapy
voided urine cytology
XVir-N-31
zinc transporter
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557142003321
Ecke Thorsten  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Oncolytic Virus Immunotherapy
Oncolytic Virus Immunotherapy
Autore Marchini Antonio
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (366 p.)
Soggetto topico Clinical and internal medicine
Medicine and Nursing
Soggetto non controllato adenovirus
adoptive T cell therapy
antigen-agnostic vaccination
antitumor immune response
arming
biomarkers
cancer
cancer immune therapy
cancer immunotherapy
cancer therapy
CAR T cell
checkpoint inhibitor
checkpoint inhibitors
class I HLA
clinical trials
colorectal cancer
combination therapy
combinatory therapy
CTLA-4
delivery
DNA methyltransferase inhibitor (DNMTi)
epigenetic silencing
genetic modification
glioblastoma
HER2
herpes simplex virus
HSV-1
immune checkpoint blockade
immune checkpoint inhibitor
immunoediting
immunogenic cell death
immunostimulatory
immunosurveillance
immunotherapy
measles virus
melanoma
multi-stage
n/a
NDV
newcastle disease virus
oncogenic signaling
oncolytic
oncolytic adenovirus
oncolytic virus
oncolytic viruses
pancreatic cancer
pancreatic ductal adenocarcinoma
parvovirus
PD-1
PD-L1
personalized oncolyticvirotherapy
RAS
reovirus
retargeted virus
small molecule
targeting
tropism retargeting
tumor
tumor microenvironment
type I interferon
vaccination
vector engineering
vesicular stomatitis virus
viral mimicry
virotherapy
αvβ6 integrin
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566462203321
Marchini Antonio  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui